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K e y  M e s s a g e s 
1. Concern about adverse effects is the most 
important barrier to human papillomavirus 
(HPV) vaccination. 
2. Vaccination strategies should focus on knowledge 
exchange and education on the safety and benefits 
versus risk to improve vaccination uptake.
3. Demand for HPV vaccines is high as indicated by 
the maximum willingness to pay. However, the 
willingness to pay for current vaccines is lower 
than the current market price. 
4. Subsidy or co-payment from the government 
should be considered to meet demand for HPV 
vaccination.
Mothers’ preference and willingness to pay for 
human papillomavirus vaccination for their 
daughters: a discrete choice experiment
X Li, ICK Wong, SM McGhee, MYW Kwan, CKH Wong, DKM Ip, J Chau, EWY Chan*
Introduction
In Hong Kong, cervical cancer is the seventh 
commonest cancer among females and accounts 
for about 3.6% of all new cancer cases. To reduce 
the disease burden, a cervical cancer screening 
programme was launched in 2004 and two vaccines 
were introduced in 2006. However, HPV vaccination 
is not included in the government immunisation 
schedule and is largely taken up in private 
clinics opportunistically. The uptake rate of HPV 
vaccination among adolescent girls in Hong Kong is 
low (2.1%-9.1%).1,2
 The success of a HPV vaccination programme 
largely depends on the local stakeholders’ attitude 
towards risks and benefits of vaccination. Our study 
used a discrete choice experiment to elicit Hong 
Kong mothers’ preference and willingness to pay 
(WTP) for HPV vaccination for their daughters.
Methods
A cross-sectional survey of mothers with daughters 
aged 8 to 17 years was conducted at the paediatric 
specialist outpatient clinics of two public hospitals 
using a stratified sampling approach. A discrete 
choice experiment was used to elicit the preferences 
and WTP of mothers. 
 The survey was delivered through Survey 
Monkey (Palo Alto, California, USA) using a portable 
device. Sociodemographic data, health and vaccine 
experiences, and the discrete choice experiment 
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responses were recorded. Trained research assistants 
screened the eligibility of participants, and written 
consent was obtained. The discrete choice experiment 
choices were analysed using a multinomial logistic 
regression model. Regression coefficients (with 95% 
confidence intervals) and WTP were reported. The 
marginal WTP for one unit change in each attribute 
was calculated by equation 1:
Marginal WTP = 
Preference Weightattribute x ΔLevelattribute  (1)      Preference Weightout-of-pocket cost
 Total WTP for vaccines was calculated by 
equation 2: 
Total WTP = Marginal WTPprotection + Marginal WTPprotection +
Marginal WTPside effects (2)
 All statistical analyses were conducted using 
Statistical Analysis System version 9.3.  
Results
A total of 482 mothers (mean age, 42.9 years) were 
interviewed with a response rate of 79.1% (Table 
1). About 58.5% of mothers were born in Hong 
Kong and about 97.4% had secondary education 
or above. About 45.5% of mothers had monthly 
household income more than HK$30 000. More 
than 75% of mothers had heard about HPV vaccines 
and were concerned about their daughters’ risk 
of HPV infection and cervical cancer. However, 
approximately 55.4% of mothers believed vaccines 
HEALTH AND MEDICAL RESEARCH FUND
Hong Kong Med J  ⎥  Volume 24 Number 5 (Supplement 6)  ⎥  October 2018  ⎥  www.hkmj.org
© 2018 Administering Institution and Hong Kong SAR Government
#  Willingness to pay for human papillomavirus vaccination  # 
35Hong Kong Med J  ⎥  Volume 24 Number 5 (Supplement 6)  ⎥  October 2018  ⎥  www.hkmj.org
are somewhat unsafe or very unsafe and some 
refused vaccine for their daughter. Approximately 
96.7% of mothers reported either sex education or 
abstinence should be taught at school, which was a 
proxy for conservative values.
 In the validity test of scenario 1, 99.4% of 
mothers made a reasonable choice with higher 
protection effectiveness, longer protection duration, 
and lower probability of adverse effects. In the actual 
discrete choice experiment of scenarios 2 to 9, 58.3% 
to 86.3% of mothers chose one of the two vaccines 
after considering the trade-off among health benefit, 
risk, and cost in each scenario. Table 2 shows the 
mothers’ preferences estimated from the statistical 
model. All attributes had a significant impact on 
the utility (P<0.001). The most important attribute 
was adverse effects, followed by protection against 
cervical cancer and protection duration. 
 The marginal WTP for each attribute and 
the overall WTP for vaccine are shown in Table 3. 
Vaccine effectiveness, defined as cervical cancer 
protection rate, was highly valued with the largest 
marginal WTP of HK$5431. Mothers were willing 
to pay similarly for lifetime protection duration 
(HK$3545) and the greatest adverse effect reduction 
from 14 to 0 in 100 mothers (HK$3550). Maximum 
WTP for ideal technology with the best of all features 
was HK$12 526. The WTP for current vaccines is 
approximately HK$1700, which is relatively lower 
than the current market price (HK$2100-4000).
Discussion
Cervical cancer is one of the deadliest and yet most 
preventable cancers. Disease burden of cervical 
cancer is relatively higher in Hong Kong than other 
developed areas, as there is no universal screening 
or vaccination programme in Hong Kong. In Hong 
Kong, HPV vaccination among teenage girls is 
largely opportunistic and the uptake rate is low.1,2 
Understanding the determinants of HPV vaccine 
uptake is crucial for designing more effective vaccine-
promotion programmes and for re-evaluating 
immunisation policies. In our study, significant 
determinants of the HPV vaccine uptake were 
cervical cancer protection effectiveness, protection 
duration, adverse effects, and out-of-pocket costs. 
 In contrast to the commonly recognised 
attribute of protection effectiveness in the US,3 
Vietnam,4 and Thailand,5 Hong Kong mothers 
weighted adverse effects as a priority when making 
choices between vaccines. This may be explained 
by differences in culture, ethnicity, and education 
levels. For example, our sample appears to be more 
conservative on sexual health issues (abstinence 
should be taught in schools: 96.7% vs 21.6%) and 
less–well educated (tertiary education or above: 
27.5% vs 39.7%), compared with US mothers.3 
Further, 55.4% of Hong Kong mothers believed 
that vaccines are somewhat unsafe or very unsafe, 
compared with only 9.8% of US mothers. This 
suggests that safety concern is the main barrier to 
vaccination uptake in Hong Kong. Education should 











Mean±standard deviation mother age, y 42.9±5.5 41.4±5.6 43.8±5.2
Place of Birth
Hong Kong 282 (58.5) 95 (52.5) 187 (62.1)
Mainland China 174 (36.1) 72 (39.8) 102 (33.9)
Others 26 (5.4) 14 (7.7%) 12 (4.0)
Education
Primary or below 27 (5.6) 15 (8.3) 12 (4.0)
Secondary 322 (66.9) 136 (75.1) 186 (61.8)
Tertiary or above 133 (27.5) 30 (16.6) 103 (34.3)
Monthly household Income 
<HK$10 000 33 (6.85) 21 (12.5) 12 (4.0)
HK$10 000-20 000 130 (27.0) 66 (36.5) 64 (21.3)
HK$20 001-30 000 84 (17.4) 28 (15.5) 56 (18.6)
HK$30 001-50 000 103 (21.4) 29 (16.2) 74 (24.6)
HK$50 001-100 000 89 (18.5) 22 (12.2) 67 (26.3)
>HK$100 000 27 (5.6) 4 (2.2) 23 (7.6)
Retired 6 (1.2) 4 (2.2) 2 (0.7)
Unemployed 10 (2.8) 7 (3.9) 3 (1.0)
Has heard of HPV vaccines before 385 (79.9) 151 (83.4) 234 (77.7)
Familiar with HPV 107 (22.2) 42 (23.2) 65 (21.6)
Familiar with cervical cancer 312 (64.7) 113 (62.4) 199 (66.1)
Knows a child/teenager who has had 
HPV vaccination
94 (19.5) 28 (15.5) 66 (21.9)
Personal history of HPV vaccination 23 (4.8) 7 (3.9) 16 (5.3)
Personal history of HPV 12 (2.5) 5 (2.8) 7 (2.3)
Personal history of cervical cancer 5 (1.0) 2 (1.1) 3 (1.0)
Personal history of other cancer 15 (3.1) 4 (2.2) 11 (3.7)
Personal history of abnormal Pap smear 
test result
26 (5.4) 9 (5.0) 17 (5.7)
Daughter has had Pap smear test 8 (1.7) 1 (0.6) 7 (2.3)
Has concerns about daughter's risk of 
HPV
363 (75.3) 135 (74.6) 228 (75.8)
Has concerns about daughter's risk of 
cervical cancer
370 (76.8) 142 (78.5) 228 (75.8)
Believes daughter not at risk of HPV 
because not sexually active
466 (96.7) 175 (96.7) 291 (96.7)
Refused vaccine for daughter 32 (6.6) 7 (3.9) 25 (8.3)
Believes vaccines are somewhat unsafe 
or very unsafe
267 (55.4) 98 (54.0) 169 (56.2)
Believes either sex education or 
abstinence should be taught at school
466 (96.7) 174 (96.1) 292 (97.0)
Abbreviation: HPV= human papillomavirus
* Data are presented as No. (%) of respondents unless otherwise stated
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focus on the safety of vaccines, and communication 
between mothers and providers on the benefits and 
risks of HPV vaccination should be encouraged as 
part of the health education programme. About 
79.9% of mothers had heard of HPV vaccines, and 
the demand and perceived health benefits of HPV 
vaccines or risks of HPV were high, as indicated 
by the maximum WTP. This might reflect the fear 
of cancer and the efforts of health education and 
advertisement for cervical cancer prevention. 
Nonetheless, the overall WTP for current vaccines 
was lower than the market price for current vaccines. 
Subsidy or co-payment from the government should 
be considered to meet demand for HPV vaccination.
 Our study has limitations. All decisions were 
made on hypothetical scenarios. Our choice sets 
considered a limited number of attributes from 
the literature and a pilot study. Other attributes, 
especially for the protection against genital warts, 
may also reflect the preference. The sample was 
from two public hospitals; response bias from the 
convenience sampling method cannot be avoided, 
and the generalisability of the findings to entire Hong 
Kong population needs to be interpreted cautiously. 
Conclusion
The perceived health benefits of HPV vaccines were 
high among Hong Kong mothers. They weighted 
concern about adverse effects as the most important 
attribute when considering HPV vaccination for 
their daughters. Their WTP was lower than the 
current market price of HPV vaccination and was 
diverse among different socio-economic groups.
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TABLE 2.  Coefficients estimates for attribute main effects using multinomial logistic regression
Attribute Preference weights Standard error (95% confidence interval) P value
Protection against cervical cancer 0.01633 0.0007514 (0.01486 to 0.0178) <0.0001
Protection duration 0.01066 0.0005 (0.00968 to 0.01164) <0.0001
Adverse effects -0.07626 0.00487 (-0.0858 to -0.0667) <0.0001
Out-of-pocket cost -0.0003007 0.0000207 (-0.0003 to -0.0003) <0.0001
TABLE 3.  Willingness to pay for the attributes of human 
papillomavirus vaccination
Attributes Marginal 
willingness to pay 
(HK$)






0 to lifetime 3545.06
0 to 10 354.51
0 to 5 177.25
0 to 2 70.90
Adverse effects, %
14 to 0 in 100 3550.52
10 to 0 in 100 2536.08
6 to 0 in 100 1521.65
2 to 0 in 100 507.22
Maximum willingness to pay* 12 526.24
Willingness to pay for current vaccine† 1619.89
* Calculated by incorporating 100% protection, lifetime 
protection (100 years), and 0% risk of adverse effects
† By incorporating 70% protection against cervical cancer, 10-
year protection duration, and 10% risk of adverse effects
